Cerebrospinal fluid β-amyloid and phospho-tau biomarker interactions affecting brain structure in preclinical Alzheimer disease.
作者： Juan Fortea , Eduard Vilaplana , Daniel Alcolea , María Carmona‐Iragui , María‐Belén Sánchez‐Saudinos
DOI: 10.1002/ANA.24186
关键词: Alzheimer's disease 、 Surrogate endpoint 、 Pathological 、 Magnetic resonance imaging 、 Atrophy 、 Cerebrospinal fluid 、 Medicine 、 Neuroimaging 、 Biomarker (medicine) 、 Pathology
摘要: … p-tau and CTh is modified by Aβ status and the relationship between Aβ and CTh is modified by p… Data used in the preparation of this article were obtained from the Alzheimer's Disease …
sci-hub.se 参考文章(40)
Juan Fortea, Roser Sala-Llonch, David Bartrés-Faz, Beatriz Bosch, Albert Lladó, Nuria Bargalló, José Luis Molinuevo, Raquel Sánchez-Valle, Increased Cortical Thickness and Caudate Volume Precede Atrophy in PSEN1 Mutation Carriers Journal of Alzheimer's Disease. ,vol. 22, pp. 909- 922 ,(2010) , 10.3233/JAD-2010-100678
David S. Knopman, Clifford R. Jack, Heather J. Wiste, Stephen D. Weigand, Prashanthi Vemuri, Val J. Lowe, Kejal Kantarci, Jeffrey L. Gunter, Matthew L. Senjem, Michelle M. Mielke, Rosebud O. Roberts, Bradley F. Boeve, Ronald C. Petersen, Brain injury biomarkers are not dependent on β-amyloid in normal elderly. Annals of Neurology. ,vol. 73, pp. 472- 480 ,(2013) , 10.1002/ANA.23816
R.S. Desikan, L.K. McEvoy, D. Holland, W.K. Thompson, J.B. Brewer, P.S. Aisen, O.A. Andreassen, B.T. Hyman, R.A. Sperling, A.M. Dale, , Apolipoprotein E epsilon4 does not modulate amyloid-β-associated neurodegeneration in preclinical Alzheimer disease American Journal of Neuroradiology. ,vol. 34, pp. 505- 510 ,(2013) , 10.3174/AJNR.A3267
H Braak, E Braak, Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories Neurobiology of Aging. ,vol. 18, pp. 351- 357 ,(1997) , 10.1016/S0197-4580(97)00056-0
Usman A Khan, Li Liu, Frank A Provenzano, Diego E Berman, Caterina P Profaci, Richard Sloan, Richard Mayeux, Karen E Duff, Scott A Small, Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer's disease Nature Neuroscience. ,vol. 17, pp. 304- 311 ,(2014) , 10.1038/NN.3606
Keith A. Josephs, Jennifer L. Whitwell, Zeshan Ahmed, Maria M. Shiung, Stephen D. Weigand, David S. Knopman, Bradley F. Boeve, Joseph E. Parisi, Ronald C. Petersen, Dennis W. Dickson, Clifford R. Jack, β‐amyloid burden is not associated with rates of brain atrophy Annals of Neurology. ,vol. 63, pp. 204- 212 ,(2008) , 10.1002/ANA.21223
Dietmar R. Thal, Udo Rüb, Mario Orantes, Heiko Braak, Phases of Aβ-deposition in the human brain and its relevance for the development of AD Neurology. ,vol. 58, pp. 1791- 1800 ,(2002) , 10.1212/WNL.58.12.1791
E. D. Roberson, K. Scearce-Levie, J. J. Palop, F. Yan, I. H. Cheng, T. Wu, H. Gerstein, G.-Q. Yu, L. Mucke, Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science. ,vol. 316, pp. 750- 754 ,(2007) , 10.1126/SCIENCE.1141736
Thomas Espeseth, Lars T. Westlye, Anders M. Fjell, Kristine B. Walhovd, Helge Rootwelt, Ivar Reinvang, Accelerated age-related cortical thinning in healthy carriers of apolipoprotein E ɛ4 Neurobiology of Aging. ,vol. 29, pp. 329- 340 ,(2008) , 10.1016/J.NEUROBIOLAGING.2006.10.030
Clifford R Jack, David S Knopman, William J Jagust, Ronald C Petersen, Michael W Weiner, Paul S Aisen, Leslie M Shaw, Prashanthi Vemuri, Heather J Wiste, Stephen D Weigand, Timothy G Lesnick, Vernon S Pankratz, Michael C Donohue, John Q Trojanowski, Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurology. ,vol. 12, pp. 207- 216 ,(2013) , 10.1016/S1474-4422(12)70291-0